← Leaderboards
Olga I Stenina
Cleveland Clinic Foundation
$4,399,741
Attributed
$5,374,122
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $721.4K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,374,122 · 5
By mechanism
R01$4,971,367 · 3
K01$383,755 · 1
R13$19,000 · 1
Top collaborators
- Edward Franklin Plow5 shared
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Jun Qin$25,653,832
- Edward Franklin Plow$29,036,723
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseRegulationMolecularCellsMouse ModelPathway InteractionsDiabetes MellitusAtherosclerosisTherapeutic InterventionThrombospondin 1LeadProteinsSignal TransductionHyperglycemiaInsightAffectAngiogenic ProteinsGene ExpressionPreventArterial Fatty StreakDiabetic AngiopathiesAngiogenesisDiabeticIn Vitro
Grant awards (21)
FASEB SRC on Matricellular Proteins in Inflammation and Tissue Remodeling$19,000
R13 · FY2019 · HL · contact PI
Tissue Specific Regulation of Diabetes-Associated Cancer Growth$328,888
R01 · FY2018 · CA · contact PI
TSP-4 genetic variants in atherogenesis and angiogenesis$392,500
R01 · FY2017 · HL
Tissue Specific Regulation of Diabetes-Associated Cancer Growth$328,888
R01 · FY2017 · CA · contact PI
TSP-4 genetic variants in atherogenesis and angiogenesis$392,500
R01 · FY2016 · HL
Tissue Specific Regulation of Diabetes-Associated Cancer Growth$328,888
R01 · FY2016 · CA · contact PI
TSP-4 genetic variants in atherogenesis and angiogenesis$386,612
R01 · FY2015 · HL
Tissue Specific Regulation of Diabetes-Associated Cancer Growth$328,888
R01 · FY2015 · CA · contact PI
TSP-4 genetic variants in atherogenesis and angiogenesis$384,650
R01 · FY2014 · HL
Tissue Specific Regulation of Diabetes-Associated Cancer Growth$328,888
R01 · FY2014 · CA · contact PI
TSP-4 genetic variants in atherogenesis and angiogenesis$392,500
R01 · FY2013 · HL
Regulation of thrombospondin-1 expression by glucose$269,264
R01 · FY2010 · DK · contact PI
Regulation of thrombospondin-1 expression by glucose$271,985
R01 · FY2009 · DK · contact PI
Regulation of thrombospondin-1 expression by glucose$1,570
R01 · FY2009 · DK · contact PI
Regulation of thrombospondin-1 expression by glucose$271,985
R01 · FY2008 · DK · contact PI
Regulation of thrombospondin-1 expression by glucose$277,536
R01 · FY2007 · DK · contact PI
Regulation of thrombospondin-1 expression by glucose$285,825
R01 · FY2006 · DK · contact PI
Proatherogenic effect of thrombospondins in diabetes$105,586
K01 · FY2005 · DK
Proatherogenic effect of thrombospondins in diabetes$95,413
K01 · FY2004 · DK
Proatherogenic effect of thrombospondins in diabetes$93,172
K01 · FY2003 · DK
Proatherogenic effect of thrombospondins in diabetes$89,584
K01 · FY2002 · DK